Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for global professionals · Monday, April 23, 2018 · 443,599,740 Articles · 3+ Million Readers

NewCardio Completes $2.9 Million Private Placement

September 21, 2009, 2009 (FinancialWire) — NewCardio, Inc., (OTCBB: NWCI) said it has closed a private placement financing with institutional and other accredited investors, including members of NewCardio’s management team and board of directors, who purchased over half of the offering. The company saw gross proceeds of around $2.9 million.

Under the deal, NewCardio issued around 2,900 shares of a new series C convertible preferred stock at $1,000 per share and convertible into around 2.9 million common shares, together with around 2.9 million common stock purchase warrants having an exercise price per share of $1.20.

Santa Clara, California-based NewCardio is a cardiac diagnostic and services company focused on the development of a proprietary platform technology. The company’s development-stage software and hardware products and services are intended to improve the diagnosis and monitoring of cardiovascular disease, as well as cardiac safety assessment of drugs under development.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Powered by EIN Presswire